Oberweis Asset Management Inc Myriad Genetics Inc Transaction History
Oberweis Asset Management Inc
- $1.86 Billion
- Q3 2024
A detailed history of Oberweis Asset Management Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Oberweis Asset Management Inc holds 360,700 shares of MYGN stock, worth $4.49 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
360,700
Previous 360,700
-0.0%
Holding current value
$4.49 Million
Previous $8.82 Million
11.9%
% of portfolio
0.53%
Previous 0.56%
Shares
7 transactions
Others Institutions Holding MYGN
# of Institutions
246Shares Held
91.6MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$189 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$128 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$83.6 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$64.4 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$58.6 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...